Cargando…

Minimally invasive image-guided therapies for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the fifth most frequently occurring cancer globally and predominantly develops in the setting of various grades of underlying chronic liver disease, which affects management decisions. Image-guided percutaneous ablative or transarterial therapies have acquired wide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelsalam, Mohamed E, Murthy, Ravi, Avritscher, Rony, Mahvash, Armeen, Wallace, Michael J, Kaseb, Ahmed O, Odisio, Bruno C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067062/ https://www.ncbi.nlm.nih.gov/pubmed/27785450 http://dx.doi.org/10.2147/JHC.S92732

Ejemplares similares

Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency
por: Smith, Justin, et al.
Publicado: (2013)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020)

Temporary Reversal of Hepatoenteric Collaterals during (90)Y Radioembolization Planning and Administration
por: Habibollahi, Peiman, et al.
Publicado: (2022)

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by (90)Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2021)

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma
por: Niekamp, Andrew, et al.
Publicado: (2018)

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
por: Mahvash, Armeen, et al.
Publicado: (2016)

A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis
por: Taiji, Ryosuke, et al.
Publicado: (2023)

Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy
por: Hosseini Shabanan, Sedighe, et al.
Publicado: (2022)

Blood flow diversion using the microvascular plug to avoid non target delivery of radioactive microspheres
por: Abdelsalam, Mohamed E., et al.
Publicado: (2020)

Hepatic Abscess following Yttrium-90 Radioembolization in Patients with Surgical Bilioenteric Anastomosis or Compromised Sphincter of Oddi: A Tertiary Cancer Center Experience
por: Agahi, Kevin N., et al.
Publicado: (2022)

Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation
por: Moawad, Ahmed W., et al.
Publicado: (2023)

Molecularly targeted photothermal ablation improves tumor specificity and immune modulation in a rat model of hepatocellular carcinoma
por: Muñoz, Nina M., et al.
Publicado: (2020)

Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?
por: Seinstra, Beatrijs A., et al.
Publicado: (2010)

Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
por: Laimer, Gregor, et al.
Publicado: (2020)

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review
por: El Kassas, Mohamed, et al.
Publicado: (2019)

Minimally invasive treatment of hepatic adenoma in special cases
por: Nasser, Felipe, et al.
Publicado: (2013)

Welcome to Journal of Hepatocellular Carcinoma
por: Kaseb, Ahmed O
Publicado: (2015)

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2022)

Editorial: charting the future of hepatocellular carcinoma publications
por: Kaseb, Ahmed Omar
Publicado: (2018)

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
por: Mohamed, Yehia I., et al.
Publicado: (2022)

Image-guided minimally invasive treatment for small renal cell carcinoma
por: Krokidis, Miltiadis E., et al.
Publicado: (2018)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
por: El Kassas, Mohamed, et al.
Publicado: (2019)

Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertension
por: Aliseda, Daniel, et al.
Publicado: (2023)

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
por: Moawad, Ahmed W, et al.
Publicado: (2020)

Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward
por: Lin, Yuan-Mao, et al.
Publicado: (2021)

Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
por: Zane, Kylie E, et al.
Publicado: (2022)

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
por: Bupathi, Manojkumar, et al.
Publicado: (2014)

Minimally Invasive Spinal Surgery with Intraoperative Image-Guided Navigation
por: Kim, Terrence T., et al.
Publicado: (2016)

Minimally invasive magnetic resonance image-guided prostate interventions
por: van Luijtelaar, Annemarijke, et al.
Publicado: (2022)

Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
por: Chamseddine, Shadi, et al.
Publicado: (2023)

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
por: Awiwi, Muhammad O, et al.
Publicado: (2022)

Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer
por: Bibok, Andras, et al.
Publicado: (2021)

Minimally Invasive Image-Guided Gut Transport Function Measurement Probe
por: Otuya, David O., et al.
Publicado: (2021)

A comment on ‘A morpho-molecular prognostic model for hepatocellular carcinoma'
por: Halil Sahin, I, et al.
Publicado: (2013)

Planting Seeds into the Lung: Image-Guided Percutaneous Localization to Guide Minimally Invasive Thoracic Surgery
por: Lee, Ji Won, et al.
Publicado: (2019)

Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience
por: Abdelsalam, Mohamed E., et al.
Publicado: (2023)

The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma
por: Economides, Minas, et al.
Publicado: (2017)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021)

Comparing voxel-based absorbed dosimetry methods in tumors, liver, lung, and at the liver-lung interface for (90)Y microsphere selective internal radiation therapy
por: Mikell, Justin K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p5kg2d4k9st96eb3v2egoomglf